NASDAQ:RMTI Rockwell Medical (RMTI) Stock Forecast, Price & News $2.08 +0.08 (+4.00%) (As of 09/29/2023 ET) Add Compare Share Share Today's Range$2.03▼$2.1950-Day Range$1.83▼$3.6152-Week Range$0.84▼$6.24Volume301,639 shsAverage Volume298,715 shsMarket Capitalization$59.26 millionP/E RatioN/ADividend YieldN/APrice Target$11.00 ProfileProfileAnalyst RatingsChartCompetitorsEarningsFinancialsInstitutional OwnershipHeadlinesOptions ChainSEC FilingsShort InterestSocial MediaSustainabilityProfileAnalyst RatingsChartCompetitorsEarningsFinancialsInstitutional OwnershipHeadlinesOptions ChainSEC FilingsShort InterestSocial MediaSustainability Rockwell Medical MarketRank™ ForecastAnalyst RatingBuy3.00 Rating ScoreUpside/Downside428.8% Upside$11.00 Price TargetShort InterestHealthy3.56% of Float Sold ShortDividend StrengthN/ASustainability-2.35Upright™ Environmental ScoreNews Sentiment0.80Based on 6 Articles This WeekInsider TradingN/AProj. Earnings GrowthGrowingFrom ($0.43) to ($0.05) Per ShareSee Full Details Hide Full Details Overall MarketRank™MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.2.35 out of 5 starsMedical Sector235th out of 970 stocksPharmaceutical Preparations Industry91st out of 449 stocks 3.5 Analyst's Opinion Consensus RatingRockwell Medical has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 1 buy rating, no hold ratings, and no sell ratings.Price Target Upside/DownsideAccording to analysts' consensus price target of $11.00, Rockwell Medical has a forecasted upside of 428.8% from its current price of $2.08.Amount of Analyst CoverageRockwell Medical has only been the subject of 1 research reports in the past 90 days. Previous Next 5.0 Short Interest Percentage of Shares Shorted3.56% of the float of Rockwell Medical has been sold short.Short Interest Ratio / Days to CoverRockwell Medical has a short interest ratio ("days to cover") of 0.8, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in Rockwell Medical has recently decreased by 20.64%, indicating that investor sentiment is improving significantly. Previous Next 0.0 Dividend Strength Dividend YieldRockwell Medical does not currently pay a dividend.Dividend GrowthRockwell Medical does not have a long track record of dividend growth. Previous Next 4.1 Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreRockwell Medical has received a 58.29% net impact score from Upright. The largest positive contribution comes from its "Physical diseases" impact, which is false driven by its "Iron deficiency medication" and "Clinical research services for deficiency diseases" products. See details.Environmental SustainabilityThe Environmental Impact score for Rockwell Medical is -2.35. Previous Next 2.7 News and Social Media Coverage News SentimentRockwell Medical has a news sentiment score of 0.80. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.68 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 6 news articles for Rockwell Medical this week, compared to 1 article on an average week.Search InterestOnly 5 people have searched for RMTI on MarketBeat in the last 30 days. This is a decrease of -50% compared to the previous 30 days.MarketBeat FollowsOnly 5 people have added Rockwell Medical to their MarketBeat watchlist in the last 30 days. This is a decrease of -17% compared to the previous 30 days. Previous Next 0.0 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Rockwell Medical insiders have not sold or bought any company stock.Percentage Held by InsidersOnly 2.20% of the stock of Rockwell Medical is held by insiders.Percentage Held by InstitutionsOnly 22.07% of the stock of Rockwell Medical is held by institutions. Previous Next 0.6 Earnings and Valuation Earnings GrowthEarnings for Rockwell Medical are expected to grow in the coming year, from ($0.43) to ($0.05) per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Rockwell Medical is -2.36, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Rockwell Medical is -2.36, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioRockwell Medical has a P/B Ratio of 1.79. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities. Previous Next See Top Rated MarketRank™ Stocks Here About Rockwell Medical (NASDAQ:RMTI) StockRockwell Medical, Inc., together with its subsidiaries, operates as a healthcare company that engages in the development, manufacture, commercialization, and distribution of various hemodialysis products for dialysis providers worldwide. The company offers Triferic Dialysate and Triferic AVNU which are indicated to maintain hemoglobin in patients undergoing hemodialysis. It also manufactures, sells, delivers, and distributes hemodialysis concentrates, such as CitraPure citric acid concentrate, Dri-Sate dry acid concentrate, RenalPure liquid acid concentrate, dry acid concentrate mixer, and RenalPure and SteriLyte powder bicarbonate concentrate; and ancillary products, including cleaning agents, 6% bleach for disinfection, citric acid descale, filtration salts, and other supplies used by hemodialysis providers. The company's dialysis concentrate products are used to maintain human life by removing toxins and replacing critical nutrients in the dialysis patient's bloodstream. It is also developing other therapeutic product candidates for the treatment of hospitalized patients with acute heart failure; and home infusion therapy that allows patients to receive intravenous medications at home. Its target customers include medium and small sized dialysis chains and independent dialysis centers. Rockwell Medical, Inc. was incorporated in 1996 and is headquartered in Wixom, Michigan.Read More RMTI Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart RMTI Stock News HeadlinesSeptember 30, 2023 | americanbankingnews.comHC Wainwright Reaffirms Buy Rating for Rockwell Medical (NASDAQ:RMTI)September 28, 2023 | finance.yahoo.comRockwell Medical Enters into 3-Year Product Purchase Agreement with Sanderling Renal Services; Expands Distribution Capabilities Westward into UtahSeptember 30, 2023 | Investor Place Media (Ad)Elon Musk May Have Just Changed EverythingQuantum computing, 3D Printing and Gene-Editing are 3 most disruptive pieces of technology in recent times. None compare to a project Elon Musk released which could mint the world’s first trillionaire. September 27, 2023 | finance.yahoo.comRockwell Medical (RMTI) Outpaces Stock Market Gains: What You Should KnowSeptember 21, 2023 | marketwatch.comRockwell Medical Extends Sales Pact With Top Customer DaVita >RMTISeptember 21, 2023 | finance.yahoo.comRockwell Medical Enters into Products Purchase Agreement with its Largest Customer, Enhancing Relationship through 2024September 18, 2023 | finance.yahoo.comLate-cycle stock sectors in focus amid U.S. economic uncertaintySeptember 7, 2023 | finance.yahoo.comRockwell Medical to Present at the H.C. Wainwright 25th Annual Global Investment Conference on Tuesday, September 12, 2023September 30, 2023 | Investor Place Media (Ad)Elon Musk May Have Just Changed EverythingQuantum computing, 3D Printing and Gene-Editing are 3 most disruptive pieces of technology in recent times. None compare to a project Elon Musk released which could mint the world’s first trillionaire. August 15, 2023 | finance.yahoo.comRockwell Medical, Inc. (NASDAQ:RMTI) Q2 2023 Earnings Call TranscriptAugust 15, 2023 | markets.businessinsider.comH.C. Wainwright Sticks to Their Buy Rating for Rockwell Med (RMTI)August 14, 2023 | finance.yahoo.comQ2 2023 Rockwell Medical Inc Earnings CallAugust 14, 2023 | markets.businessinsider.comRockwell Medical Boosts Full-year Sales Outlook, Speeds Up Profitability TimelineAugust 14, 2023 | markets.businessinsider.comWhy Rockwell Medical Shares Are Surging TodayAugust 14, 2023 | businesswire.comRockwell Medical Announces Second Quarter 2023 ResultsAugust 7, 2023 | msn.comRockwell Medical: Upside Potential Outweighs Competition RiskAugust 1, 2023 | finance.yahoo.comVAREX IMAGING (VREX) Surpasses Q3 Earnings and Revenue EstimatesJuly 27, 2023 | finance.yahoo.comRockwell Medical (RMTI) Gains As Market Dips: What You Should KnowJuly 21, 2023 | finance.yahoo.comRockwell Medical (RMTI) Stock Sinks As Market Gains: What You Should KnowJuly 20, 2023 | thestreet.comRockwell Medical (RMTI) Stock Falls After Company Prices Public OfferingJuly 17, 2023 | markets.businessinsider.comRockwell Medical On Course To Reach Profitability By Late 2024, Analyst SaysJuly 17, 2023 | finance.yahoo.comRockwell Medical to Release Second Quarter 2023 Financial Results on Monday, August 14, 2023July 12, 2023 | finance.yahoo.comInstitutions own 6.9% of Rockwell Medical, Inc. (NASDAQ:RMTI) shares but individual investors control 41% of the companyJuly 11, 2023 | msn.comWhat's Going On With Rockwell Medical (RMTI) StockJuly 11, 2023 | finance.yahoo.comRockwell Medical Acquires Hemodialysis Concentrates Business from Evoqua Water TechnologiesJuly 3, 2023 | finance.yahoo.comWhat Makes Rockwell Medical (RMTI) a Good Fit for 'Trend Investing'July 3, 2023 | finance.yahoo.comRockwell Medical (RMTI) Soars 20.0%: Is Further Upside Left in the Stock?See More Headlines Receive RMTI Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Rockwell Medical and its competitors with MarketBeat's FREE daily newsletter. Email Address RMTI Company Calendar Last Earnings8/14/2023Today9/30/2023Next Earnings (Estimated)11/13/2023Fiscal Year End12/31/2023Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ Industry Pharmaceutical preparations Sub-IndustryHealth Care Equipment SectorMedical Current SymbolNASDAQ:RMTI CUSIP77437410 CIK1041024 Webwww.rockwellmed.com Phone(248) 432-1362Fax248-960-9119Employees253Year Founded1995Price Target and Rating Average Stock Price Forecast$11.00 High Stock Price Forecast$11.00 Low Stock Price Forecast$11.00 Forecasted Upside/Downside+428.8%Consensus RatingBuy Rating Score (0-4)3.00 Research Coverage1 Analysts Profitability EPS (Most Recent Fiscal Year)($0.88) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-18,680,000.00 Net Margins-15.32% Pretax Margin-15.32% Return on Equity-88.74% Return on Assets-25.89% Debt Debt-to-Equity Ratio0.69 Current Ratio1.58 Quick Ratio1.25 Sales & Book Value Annual Sales$72.81 million Price / Sales0.81 Cash FlowN/A Price / Cash FlowN/A Book Value$1.16 per share Price / Book1.79Miscellaneous Outstanding Shares28,490,000Free Float27,863,000Market Cap$59.26 million OptionableOptionable Beta1.40 Social Links Elon Musk's Next MoveWondering when you'll finally be able to invest in SpaceX, StarLink or The Boring Company? Click the link below to learn when Elon Musk will let these companies finally IPO.Get This Free Report Key ExecutivesDr. Mark Strobeck Ph.D. (Age 52)Pres, CEO & Director Comp: $643.41kMs. Megan C. Timmins (Age 50)Exec. VP, Chief Legal Officer & Sec. Comp: $518.09kMr. Paul E. McGarry (Age 55)SVP of Fin. & Chief Accounting Officer Mr. James A. McCarthySr. VP of Bus. & Corp. Devel.Mr. Timothy T. CholeSr. VP of Sales & MarketingMs. Heather R. HunterSr. VP & Chief Corp. Affairs OfficerMr. David J. Kull (Age 55)Sec. Mr. Jason FinkelsteinInvestor Relations RepresentativeMore ExecutivesKey CompetitorsMinerva NeurosciencesNASDAQ:NERVClearside BiomedicalNASDAQ:CLSDVistagen TherapeuticsNASDAQ:VTGNHookipa PharmaNASDAQ:HOOKRezoluteNASDAQ:RZLTView All CompetitorsInstitutional OwnershipTucker Asset Management LLCBought 52,049 shares on 9/8/2023Ownership: 0.183%Osaic Holdings Inc.Bought 5,100 shares on 8/21/2023Ownership: 0.055%XTX Topco LtdBought 23,208 shares on 8/15/2023Ownership: 0.169%Citadel Advisors LLCBought 13,700 shares on 8/15/2023Ownership: 0.000%Tower Research Capital LLC TRC Bought 5,447 shares on 8/14/2023Ownership: 0.075%View All Institutional Transactions RMTI Stock - Frequently Asked Questions Should I buy or sell Rockwell Medical stock right now? 1 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Rockwell Medical in the last twelve months. There are currently 1 buy rating for the stock. The consensus among Wall Street research analysts is that investors should "buy" RMTI shares. View RMTI analyst ratings or view top-rated stocks. What is Rockwell Medical's stock price forecast for 2023? 1 Wall Street research analysts have issued twelve-month target prices for Rockwell Medical's shares. Their RMTI share price forecasts range from $11.00 to $11.00. On average, they expect the company's stock price to reach $11.00 in the next year. This suggests a possible upside of 428.8% from the stock's current price. View analysts price targets for RMTI or view top-rated stocks among Wall Street analysts. How have RMTI shares performed in 2023? Rockwell Medical's stock was trading at $1.0150 on January 1st, 2023. Since then, RMTI shares have increased by 104.9% and is now trading at $2.08. View the best growth stocks for 2023 here. Are investors shorting Rockwell Medical? Rockwell Medical saw a drop in short interest in September. As of September 15th, there was short interest totaling 888,800 shares, a drop of 20.6% from the August 31st total of 1,120,000 shares. Based on an average daily volume of 1,100,000 shares, the days-to-cover ratio is currently 0.8 days. Currently, 3.6% of the shares of the stock are short sold. View Rockwell Medical's Short Interest. When is Rockwell Medical's next earnings date? The company is scheduled to release its next quarterly earnings announcement on Monday, November 13th 2023. View our RMTI earnings forecast. How were Rockwell Medical's earnings last quarter? Rockwell Medical, Inc. (NASDAQ:RMTI) announced its quarterly earnings data on Monday, August, 14th. The company reported ($0.18) EPS for the quarter, missing analysts' consensus estimates of ($0.12) by $0.06. The company had revenue of $18.08 million for the quarter, compared to analysts' expectations of $18.08 million. Rockwell Medical had a negative trailing twelve-month return on equity of 88.74% and a negative net margin of 15.32%. During the same period last year, the firm posted ($0.56) earnings per share. When did Rockwell Medical's stock split? Rockwell Medical's stock reverse split on Friday, May 13th 2022. The 1-11 reverse split was announced on Friday, May 13th 2022. The number of shares owned by shareholders was adjusted after the closing bell on Friday, May 13th 2022. An investor that had 100 shares of stock prior to the reverse split would have 9 shares after the split. What guidance has Rockwell Medical issued on next quarter's earnings? Rockwell Medical issued an update on its FY 2023 earnings guidance on Sunday, September, 3rd. The company provided earnings per share guidance of for the period. The company issued revenue guidance of $82.00 million-$86.00 million, compared to the consensus revenue estimate of $86.08 million. What is Robert L. Chioini's approval rating as Rockwell Medical's CEO? 6 employees have rated Rockwell Medical Chief Executive Officer Robert L. Chioini on Glassdoor.com. Robert L. Chioini has an approval rating of 22% among the company's employees. This puts Robert L. Chioini in the bottom 10% of approval ratings compared to other CEOs of publicly-traded companies. What other stocks do shareholders of Rockwell Medical own? Based on aggregate information from My MarketBeat watchlists, some companies that other Rockwell Medical investors own include Immunomedics (IMMU), JinkoSolar (JKS), Seagen (SGEN), Geron (GERN), OPKO Health (OPK), Amarin (AMRN), Gilead Sciences (GILD), ImmunoGen (IMGN), Sorrento Therapeutics (SRNE) and VBI Vaccines (VBIV). What is Rockwell Medical's stock symbol? Rockwell Medical trades on the NASDAQ under the ticker symbol "RMTI." How do I buy shares of Rockwell Medical? Shares of RMTI stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. Compare Top Brokerages Here. What is Rockwell Medical's stock price today? One share of RMTI stock can currently be purchased for approximately $2.08. How much money does Rockwell Medical make? Rockwell Medical (NASDAQ:RMTI) has a market capitalization of $59.26 million and generates $72.81 million in revenue each year. The company earns $-18,680,000.00 in net income (profit) each year or ($0.88) on an earnings per share basis. How many employees does Rockwell Medical have? The company employs 253 workers across the globe. How can I contact Rockwell Medical? Rockwell Medical's mailing address is 411 HACKENSACK AVENUE SUITE 501, HACKENSACK NJ, 07601. The official website for the company is www.rockwellmed.com. The company can be reached via phone at (248) 432-1362, via email at invest@rockwellmed.com, or via fax at 248-960-9119. This page (NASDAQ:RMTI) was last updated on 9/30/2023 by MarketBeat.com Staff Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Rockwell Medical, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.